MetGen

📍 Kaarina, Finland🗓 Founded 2008👥 28 employees💰 Last funded Sep 2016
Biotechnology Research🌐 metgen.com
Website LinkedIn
We design and market novel enzymatic solutions for the most challenging of industrial conditions to meet our customers need. MetGen’s enzymes – MetZyme® – are industrial, highly-active, natural catalysts that accelerate chemical reactions. They can survive in harsh industrial environments which enables novel applications and combination with other enzymes. MetGen products are protected by international patents. Offering customized projects to meet customer’s specific needs, MetGen uses advances in genetic engineering and microbiology to adapt enzymes to harsh industrial conditions and to handle a variety of lignocellulosic substrates. MetGen has achieved successful industrial trials with sector leaders in the forest and renewable chemicals. In 2014 MetGen Oy has won the Best in BioFuel / BioEnergy category for the Global Cleantech Cluster Association (GCCA) 2014 Later Stage Award. The GCCA’s Global Top 10 Winners represent the best of the association’s 52 member clusters and over 10,000 member companies.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
1
Frequently asked questions
Who invested in MetGen?
MetGen has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did MetGen last raise funding?
The most recent investment in MetGen recorded on gritt.io was in September 2016.
When was MetGen founded?
MetGen was founded in 2008.
What industry is MetGen in?
MetGen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MetGen based?
MetGen is headquartered in Kaarina, Finland.